🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

𝗡𝗶𝗵𝗮𝗿 𝗗𝗲𝘀𝗮𝗶 MD, DM Journal of Brown Hospital Medicine Dr. Akhil 🇮🇳 Leelssss Dr Aditya Gudheniya Keith Siau Nico Gagelmann Gonzalo Bentolila This is a though one!!! Congenital dyserythropoietic anemia Type I (AR): Thin nuclear bridges b/w nuclei of erythroblasts Type II (AR): (+) HEMPAS test Type III (AD): Giant multinucleated erythroblasts Mutations: CDAN1, C15orf41, SEC23B, KIF23 sciencedirect.com/science/articl…

We now a checkpoint for NK cells ! Great work Katy Rezvani, M.D., Ph.D and team Knocking out CREM can enhance NK cell kill as anti Tumor therapy 👏👏👏

Checkpoints for NK cells !

Satya Prakash Yadav Katy Rezvani, M.D., Ph.D Impressive findings! The role of checkpoints like CREM in regulating NK cells is vital in the fight against tumors. Expanding on how CRISPR is used to modulate these checkpoints could unlock new therapeutic strategies. How do you envision translating these laboratory results into

Jai Jagan nath ! With this name this myeloma study was blessed right from beginning . Wonderful and dramatic success in Myeloma field Heartening news for myeloma patients globally

Carl June is one name that reshaped medicine. This tribute article charts his journey from Navy doctor to #CART pioneer, highlighting how his vision and compassion launched a new era of cellular therapy and saved thousands of lives. Read the article: ow.ly/W1B050W2Amc

Would TAT reach popularity reached by #BGT Ind vs Aus

#Blockurdate 12/6/25, 7-8 pm ECHO online CME CML - From root to remedies Dr Manas Kalra Satya Prakash Yadav Shruti Kakkar Vinay Munikoty Venkatesh Gargi Das Deepak Bansal Shweta Bansal Dr Neha Rastogi Pritam Singha Roy MD, DM Bharat Agarwal Badira Cheriyalinkal Parambil

#BLOCKURDATE 10th Midterm PHO CME 2025 PGICH #Noida Learn more about #PedALL & #thalassemia #Registrations open Dr Manas Kalra Nita Radhakrishnan Shruti Kakkar Satya Prakash Yadav Silky Jain Shweta Bansal Dr Neha Rastogi Anand KC Pritam Singha Roy MD, DM Dr Gaurav Kharya

Common Inherited Red Cell Disorders in One Slide 👇👇👇 #medicine #medtwitter #blooducation #hematology

Similar experience at our centre ! No response to Jakavi in Ph like ALL Nitin Jain Thanks for doing this trial and settling this issue

Powerless engines and a Dreamliner crashes within 60 sec of take off ! 241 out 242 people died. Absolutely shocking. Heart goes out to all the families who lost their family members A thorough investigation needed to find out cause The Boeing Company Air India #AirIndiaPlaneCrash

In a matter of moments, a lifetime of dreams turned to ash. A brutal reminder, life is terrifyingly fragile. Everything you build, everything you hope for, everything you love, it all hangs by a thread. So while you can, live, love, and don’t wait for happiness to start tomorrow

White lightening ! Allan Donald was the best

Gene therapy could correct blood stem cells inside, rather than outside, the body nature nature.com/articles/d4158… nature.com/articles/s4158…

Presented at #EHA2025: Among patients undergoing stem-cell transplantation from matched related donors, cyclophosphamide plus cyclosporin led to significantly longer GVHD-free, relapse-free survival than standard prophylaxis. Full ALLG BM12 CAST phase 3 trial results:

It was biggest collective failure of a highly talented and skilled bunch of test players ! No purpose and no motivation to win India defeated itself ! If South Africa wins today then we know best team didn’t win but the team with highest desperation and grittiness won it

… and finally South Africa win big after choking so many times But this time they win biggest trophy of cricket #WTC2025 Markham one man just pulled the rug under Aussies feet and won the championship for proteas

Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed NPM1-Mutated or KMT2A-Rearranged AML | Journal of Clinical Oncology ascopubs.org/doi/full/10.12… Congratulations to Dr. Zeidner and BeatAML team. 1. Revumenib was given continuously, dose adjusted for CYP3A4i 2. Ven for 28